Copyright © 2024. Published by Elsevier Inc.
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 266(2024) vom: 23. Sept., Seite 110327
|
| Auteur principal: |
Watany, Mona M
(Auteur) |
| Autres auteurs: |
Elhosary, Marwa M,
El-Horany, Hemat E,
El-Horany, Mahmoud E |
| Format: | Article en ligne
|
| Langue: | English |
| Publié: |
2024
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
| Sujets: | Journal Article
Active demyelination
IRAK-M
Interleukin-1 receptor-associated kinase-3 (IRAK-3)
Multiple sclerosis
Myeloid differentiation primary response 88 (MyD88)
Nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB)
Relapse
Interleukin-1 Receptor-Associated Kinases
EC 2.7.11.1
plus...
Myeloid Differentiation Factor 88
IRAK3 protein, human
NF-kappa B
MYD88 protein, human
Biomarkers
RNA, Messenger |